After 30 years in development, the first-ever malaria vaccine has received a positive recommendation from a European Medicines Agency (EMA) committee. GlaxoSmithKline announced this morning that Mosquirix, which has been developed specifically for use on African babies, will go on to be reviewed by the World Health Organization (WHO) before individual governments decide when and how to administer the life-saving drug. According to clinical studies, the vaccine could save hundreds of thousands of lives in Africa, where most of the victims of malaria are under the age of five.
Read the rest of First-ever malaria vaccine could save hundreds of children in Africa
via Green Living - Building, Home, Auto & Lifestyles copy http://ift.tt/1IiV9MU
No comments:
Post a Comment